# SERPASIL-ESIDRIX #2
> **NDA011878** · New Drug Application · Sponsor: NOVARTIS · Approved 1959-05-05
## Drug
- **FDA Application Number:** NDA011878
- **Application type:** New Drug Application
- **Brand name:** SERPASIL-ESIDRIX #2
- **Generic name:** Hydrochlorothiazide
- **Active ingredients:** HYDROCHLOROTHIAZIDE; RESERPINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** NOVARTIS
- **First approval:** 1959-05-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011878)
---
*AI Analytics · CC0 1.0*